Tepha

Tepha is a medical device firm pursuing the development and commercialization of innovative products based on the company's proprietary biomaterial technology. The technology provides a new class of absorbable biomaterials, known as polyhydroxyalkanoates , which may be tailored to meet unmet needs for medical devices in multiple fields. Tepha's novel, biosynthetically produced materials offer superior performance in flexibility, elasticity, and biocompatibility; and, for its fiber-based products, excellent tensile strength and strength retention.

Tepha headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device sector. The company focuses on Biotechnology and has secured $5.1B in funding across 84 round(s). With a team of 51-100 employees, Tepha is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Tepha, raised $10.7M. Discover more about their projects, partnerships, and impact on our platform.